Table of Contents Author Guidelines Submit a Manuscript
Clinical Study
Journal of Osteoporosis
Volume 2017, Article ID 4982312, 1 page
https://doi.org/10.1155/2017/4982312
Corrigendum

Corrigendum to “Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy”

1Department of Medicine, University of Texas, Southwestern Medical Center, Dallas, TX 75390, USA
2Departments of Clinical Sciences and Medicine, University of Texas, Southwestern Medical Center, Dallas, TX 75390, USA
3Department of Nuclear Medicine, Dallas Veterans Affairs Medical Center, Dallas, TX 75216, USA
4Department of Medicine, Dallas Veterans Affairs Medical Center and University of Texas, Southwestern Medical Center, Dallas, TX 75216, USA

Correspondence should be addressed to Ugis Gruntmanis; ude.nretsewhtuostu@sinamtnurg.sigu

Received 19 April 2017; Accepted 7 May 2017; Published 12 July 2017

Copyright © 2017 Katherine Neubecker et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


In the article titled “Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy” [1], there was an error regarding the FRAX® tool, which should be clarified as follows.

The article notes, “Fracture Risk Assessment (FRAX) is an algorithm developed by the World Health Organization to determine fracture risk of men and women .” However, the World Health Organization (WHO) did not develop, test, or endorse the FRAX tool or its recommendations [2]. The metabolic bone disease unit at the University of Sheffield that developed FRAX was a WHO Collaborating Centre from 1991 to 2010, but treatment guidelines must undergo a formal process before they can be endorsed by the WHO.

References

  1. K. Neubecker, B. Adams-Huet, I. M. Farukhi, R. C. Delapena, and U. Gruntmanis, “Predictors of fracture risk and bone mineral density in men with prostate cancer on androgen deprivation therapy,” Journal of Osteoporosis, vol. 2011, Article ID 924595, 6 pages, 2011. View at Publisher · View at Google Scholar
  2. N. Ford, S. L. Norris, and S. R. Hill, “Clarifying WHO’s position on the FRAX® tool for fracture prediction,” Bulletin of the World Health Organization, vol. 94, no. 862, 2016. View at Publisher · View at Google Scholar